Polyclonal Antibody to Lipolysis Stimulated Lipoprotein Receptor (LSR)

Host

Rabbit

Clone Number

Ig Isotype

Organism species

Homo sapiens (Human)

Concentration

500µg/mL

Application

WB; IHC; ICC; IP.

Alternative Names

LISCH7; ILDR3; LISCH; Lipolysis-Stimulated Remnant; Immunoglobulin-Like Domain Containing Receptor 3

Item Names

Lipolysis Stimulated Lipoprotein Receptor

Research Area

Metabolic pathway;

Citation

LSR antibody therapy inhibits ovarian epithelial tumor growth by inhibiting lipid uptake;

Buffer Formulation

PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

Immunogen

RPD744Hu01-Recombinant Lipolysis Stimulated Lipoprotein Receptor (LSR)

Usage

Western blotting: 0.2-2µg/mL;1:250-2500
Immunohistochemistry: 5-20µg/mL;1:25-100
Immunocytochemistry: 5-20µg/mL;1:25-100
Optimal working dilutions must be determined by end user.

Traits

Liquid

Purification

Antigen-specific affinity chromatography followed by Protein A affinity chromatography